1416374-98-5

Basic information

• Product Name: tert-butyl (1-ethenyl-2-oxabicyclo[2.2.2]oct-4-yl)carbamate
• CAS NO: 1416374-98-5
• Molecular Weight: 253.342
• Mol File: 1416374-98-5.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 339.6±41.0 °C(Predicted)
• Density: 1.07±0.1 g/cm3(Predicted)
• CAS DataBase Reference: tert-butyl (1-ethenyl-2-oxabicyclo[2.2.2]oct-4-yl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (1-ethenyl-2-oxabicyclo[2.2.2]oct-4-yl)carbamate(1416374-98-5)
• EPA Substance Registry System: tert-butyl (1-ethenyl-2-oxabicyclo[2.2.2]oct-4-yl)carbamate(1416374-98-5)

Safety Data

• Hazardous Substances Data: 1416374-98-5(Hazardous Substances Data)

Upstream product

• 1256546-72-1 [8-(hydroxymethyl)-1,4-dioxaspiro[4.5]decan-8-yl]methanol 
• 340023-04-3 1-vinyl-2-oxabicyclo[2.2.2]octane-4-carboxylic acid 
• 865-47-4 potassium tert-butylate 
• 340023-03-2 (1-vinyl-2-oxabicyclo[2.2.2]octan-4-yl)methanol 
• 340023-02-1 (1-vinyl-2-oxabicyclo[2.2.2]octan-4-yl)methyl acetate 
• 340022-81-3 (4-oxocyclohexane-1,1-diyl)bis(methylene) bis(4-methylbenzenesulfonate) 
• 1257050-69-3 1,4-dioxaspiro[4.5]decane-8,8-diylbis(methylene) bis(4-methylbenzenesulfonate) 
• 1256546-71-0 8,8-diethyl 1,4-dioxaspiro[4.5]decane-8,8-dicarboxylate 
• 55704-60-4 4-oxo-cyclohexane-1,1-dicarboxylic acid diethyl ester 
• 57899-62-4 triethyl 4-oxocyclohexane-1,1,3-tricarboxylate 

Downstream Products

• 1417551-42-8 tert-butyl N-(4-formyl-3-oxabicyclo[2.2.2]octan-1-yl)carbamate 

Relevant articles and documents

SUBSTITUTED CYCLOALKYLS AS MODULATORS OF THE INTEGRATED STRESS PATHWAY

Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases, disorders and conditions.

Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents

Bacterial resistance is eroding the clinical utility of existing antibiotics necessitating the discovery of new agents. Bacterial type II topoisomerase is a clinically validated, highly effective, and proven drug target. This target is amenable to inhibit